Potential 2 BLOCKBUSTER DRUGS

Discussion in 'TherapeuticsMD' started by anonymous, Mar 1, 2017 at 7:02 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    TherapeuticsMD will be launching in Q4 a potential Block Buster drug for the treatment of VVA in the women's health arena. By 2018, they will launch a 2nd drug for menopausal women experiencing hot flashes that has the potential to be even bigger. This is all according to Inventive Health who is recruiting for experienced sales reps in Women's Health.

    What Inventive didn't tell me was whether or not stock options are a part of the compensation package. I have 15 years in the arena and would love to join a start up with two potential huge products. Does anyone know if Therapeutics' comp package includes stock options, or are the current reps the only ones with equity in this company? Sounds like a great opportunity.

    Thanks for any insight.
     

  2. anonymous

    anonymous Guest

     
  3. anonymous

    anonymous Guest

    Blockbuster products? Really? We have two products that will be coming soon that are in categories where the present offerings are just fine. These new products really don't increase the value to the prescriber or patient. This is a pump and dump company looking for a quick buy out. Probably explains why the are using a cso.
     
  4. anonymous

    anonymous Guest

    I was contacted by Inventiv as well. Are most of the Therapeutics reps hired in house or through Inventive? I am looking to work directly for Inventiv
     
  5. anonymous

    anonymous Guest

    What is the salary range and bonus potential?
     
  6. anonymous

    anonymous Guest

    I heard the salary is 60K.
    No stock options. No negotiating.
    Bonus is only good if it is actually paid.
    As the current reps - have you ever been paid any significant bonus??